0001209191-23-018482.txt : 20230314
0001209191-23-018482.hdr.sgml : 20230314
20230314163615
ACCESSION NUMBER: 0001209191-23-018482
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORTIMER IAN
CENTRAL INDEX KEY: 0001619961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 23731547
MAIL ADDRESS:
STREET 1: C/O XENON PHARMACEUTICALS INC.
STREET 2: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G4W8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-10
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001619961
MORTIMER IAN
200 - 3650 GILMORE WAY
BURNABY
A1
V5G 4W8
BRITISH COLUMBIA, CANADA
1
1
0
0
PRESIDENT & CEO
Stock Option (Right to Buy)
34.18
2023-03-10
4
A
0
380000
0.00
A
2033-03-09
Common Shares
380000
380000
D
Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
/s/ Cassandra Robinson, Attorney-in-fact
2023-03-14